Multiple sclerosis - Related fatigue

Physical Medicine and Rehabilitation Clinics of North America

Volumn 16, Issue 2, 2005, Pages 483-502

  MacAllister, William S ^a   Krupp, Lauren B ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIAMINOPYRIDINE; 4 AMINOPYRIDINE; ALPRAZOLAM; AMANTADINE; AMFEBUTAMONE; AMINOPYRIDINE DERIVATIVE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BACLOFEN; BETA INTERFERON; BETA1A INTERFERON; BUTALBITAL; CARBAMAZEPINE; CARISOPRODOL; CETIRIZINE; CLOMIPRAMINE; CLONAZEPAM; CLOZAPINE; DIAZEPAM; DIPHENHYDRAMINE; FLUOXETINE; GABAPENTIN; HISTAMINE DERIVATIVE; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; INTERFERON; INTERFERON BETA SERINE; MEDROXYPROGESTERONE ACETATE; MODAFINIL; MUSCLE RELAXANT AGENT; NEFAZODONE; NEUROLEPTIC AGENT; NEUROTRANSMITTER; OPIATE; OXYCODONE; PEMOLINE; PEMOLINE MAGNESIUM; PLACEBO; PROKARIN; RISPERIDONE; SEDATIVE AGENT; SERTRALINE; TIZANIDINE; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM; VENLAFAXINE; ZOLPIDEM TARTRATE;

AGITATION; ALLERGY; ANXIETY; ANXIETY DISORDER; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CLINICAL TRIAL; COOLING; DEPRESSION; DIET; DIZZINESS; DRUG INDUCED HEADACHE; ENDOCRINE FUNCTION; ENERGY CONSERVATION; EXERCISE; FATIGUE; HAY FEVER; HORMONE SUBSTITUTION; HUMAN; IMMUNE SYSTEM; INSOMNIA; IRRITABILITY; LIVER TOXICITY; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; NAUSEA; NERVOUSNESS; NEUROIMAGING; PAIN; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; RESTLESSNESS; REVIEW; SCHIZOPHRENIA; SEIZURE; SIDE EFFECT; SLEEP DISORDER; SPASTICITY; SYMPTOM; THYROID FUNCTION; TOXIC HEPATITIS; VIVID DREAM;

ANTIDEPRESSIVE AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CRYOTHERAPY; DOPAMINE AGENTS; EXERCISE THERAPY; FATIGUE; HUMANS; MULTIPLE SCLEROSIS; PATIENT CARE PLANNING; QUALITY OF LIFE;

EID: 18944368332     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmr.2005.01.014     Document Type: Review

References (85)

1. R.K. Price, C.S. North, and S. Wessely Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community Public Health Rep 107 5 1992 514 522
2. L.B. Krupp, N.G. La Rocca, and L.C. Scheinberg Fatigue in multiple sclerosis Arch Neurol 45 4 1988 435 437
3. Multiple Sclerosis Council for Clinical Practice Guidelines Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis 1998 Paralyzed Veterans of America Washington, DC
4. J.E. Freal, G.H. Kraft, and J.K. Coryell Symptomatic fatigue in multiple sclerosis Arch Phys Med Rehabil 65 3 1984 135 138
5. Multiple Sclerosis Society of Great Britain and Northern Ireland. Symptom management survey. London: Multiple Sclerosis Society of Great Britain and Northern Ireland; 1998.
6. L. Scheinberg, N. Holland, and N. LaRocca Multiple sclerosis; earning a living N Y State J Med 80 9 1980 1395 1400
7. J. Iriarte, G. Katsamakis, and P. de Castro The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis Mult Scler 5 1 1999 10 16
8. J.D. Fisk, A. Pontefract, and P.G. Ritvo The impact of fatigue on patients with multiple sclerosis Can J Neurol Sci 21 1 1994 9 14
9. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 11 1983 1444 1452
10. T.J. Murray Amantadine therapy for fatigue in multiple sclerosis Can J Neurol Sci 12 3 1985 251 254
11. R. Bakshi, R.S. Miletich, and K. Henschel Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients Neurology 53 5 1999 1151 1153
12. C. Mainero, J. Faroni, and C. Gasperini Fatigue and magnetic resonance imaging activity in multiple sclerosis J Neurol 246 6 1999 454 458
13. C. Colosimo, E. Millefiorini, and M.G. Grasso Fatigue in MS is associated with specific clinical features Acta Neurol Scand 92 5 1995 353 355
14. J. Monks Experiencing symptoms in chronic illness: fatigue in multiple sclerosis Int Disabil Stud 11 2 1989 78 83
15. K.J. Aronson Quality of life among persons with multiple sclerosis and their caregivers Neurology 48 1 1997 74 80
16. R. Bakshi, Z.A. Shaikh, and R.S. Miletich Fatigue in multiple sclerosis and its relationship to depression and neurologic disability Mult Scler 6 2000 181 185
17. J. Iriarte, M.L. Subira, and P. Castro Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors Mult Scler 6 2 2000 124 130
18. S. Wessely, M. Hotopf, and M. Sharpe Chronic fatigue and its syndromes 1999 Oxford University Press London
19. T.H. Jones, S. Wadler, and K.H. Hupart Endocrine-mediated mechanisms of fatigue during treatment with interferon-alpha Semin Oncol 25 1 Suppl 1 1998 54 63
20. G. Giovannoni, A.J. Thompson, and D.H. Miller Fatigue is not associated with raised inflammatory markers in multiple sclerosis Neurology 57 4 2001 676 681
21. L.K. Neilley, D.S. Goodin, and D.E. Goodkin Side effect profile of interferon beta-1b in MS: results of an open label trial Neurology 46 2 1996 552 554
22. J.R. Quesada, M. Talpaz, and A. Rios Clinical toxicity of interferons in cancer patients: a review J Clin Oncol 4 2 1986 234 243
23. K. Gottberg, A. Gardulf, and S. Fredrikson Interferon-beta treatment for patients with multiple sclerosis: the patients' perceptions of the side-effects Mult Scler 6 5 2000 349 354
24. Avonex (interferon beta 1a) prescribing information 1996 Biogen Cambridge (MA)
25. Rebif (interferon beta-1a) prescribing information 2003 Serono, Inc. Rockland (MA)
26. Betaseron (interferon beta-1b) prescribing information 2003 Berlex Laboratories Montville (NJ)
27. M.U. Goebel, J. Baase, and V. Pithan Acute interferon beta-1b administration alters hypothalamic-pituitary-adrenal axis activity, plasma cytokines and leukocyte distribution in healthy subjects Psychoneuroendocrinology 27 8 2002 881 892
28. L.E. Rothuizen, T. Buclin, and F. Spertini Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers J Neuroimmunol 99 1 1999 131 141
29. M. Filippi, M.A. Rocca, and B. Colombo Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis Neuroimage 15 3 2002 559 567
30. R. Bakshi, R.S. Miletich, and P.R. Kinkel High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis J Neuroimaging 8 4 1998 228 234
31. U. Roelcke, L. Kappos, and S.J. Lechner Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study Neurology 48 6 1997 1566 1571
32. C. Mainero, J. Faroni, and C. Gasperini Fatigue and magnetic resonance imaging activity in multiple sclerosis J Neurol 246 6 1999 454 458
33. R. Bakshi Fatigue associated with multiple sclerosis: diagnosis, impact and management Mult Scler 9 3 2003 219 227
34. G.L. Sheean, N.M. Murray, and J.C. Rothwell An electrophysiological study of the mechanism of fatigue in multiple sclerosis Brain 120 Pt 2 1997 299 315
35. A.V. Ng, and J.A. Kent-Braun Quantitation of lower physical activity in persons with multiple sclerosis Med Sci Sports Exerc 29 4 1997 517 523
36. S.R. Schwid, A.D. Goodman, and D.H. Mattson Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b Arch Neurol 54 9 1997 1169 1190
37. A.J. Parker, S. Wessely, and A.J. Cleare The neuroendocrinology of chronic fatigue syndrome and fibromyalgia Psychol Med 31 8 2001 1331 1345
38. K.M. Heilman, and R.T. Watson Fatigue Neurol Network Comment 1 1997 283 287
39. T.E. Scammell, I.V. Estabrooke, and M.T. McCarthy Hypothalamic arousal regions are activated during modafinil-induced wakefulness J Neurosci 20 22 2000 8620 8628
40. K. Foglio, E. Clini, and D. Facchetti Respiratory muscle function and exercise capacity in multiple sclerosis Eur Respir J 7 1 1994 23 28
41. S. Happe Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management Drugs 63 24 2003 2725 2737
42. C.M. Clark, J.A. Fleming, and D. Li Sleep disturbance, depression, and lesion site in patients with multiple sclerosis Arch Neurol 49 6 1992 641 643
43. E. Stenager, L. Knudsen, and K. Jensen Acute and chronic pain syndromes in multiple sclerosis Acta Neurol Scand 84 3 1991 197 200
44. P. Flachenecker, T. Kumpfel, and B. Kallmann Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters Mult Scler 8 6 2002 523 526
45. F. Friedberg, and L.B. Krupp A comparison of cognitive behavioral treatment of chronic fatigue syndrome and primary depression Clin Infect Dis 18 1994 S105 S110
46. C.E. Schwartz, L. Coulthard-Morris, and Q. Zeng Psychosocial correlates of fatigue in multiple sclerosis Arch Phys Med Rehabil 77 2 1996 165 170
47. A. Zonana-Nacach, J.M. Roseman, and G. McGwin Jr. Systemic lupus erythematosus in three ethnic groups. VI: factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations: NAture vs Nurture Lupus 9 2 2000 101 109
48. Multiple Sclerosis Council for Clinical Practice Guidelines 1998 Paralyzed Veterans Association Washington, DC
49. L.B. Krupp, N.G. LaRocca, and J. Muir-Nash The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus Arch Neurol 46 10 1989 1121 1123
50. B.G. Weinshenker, M. Penman, and B. Bass A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis Neurology 42 8 1992 1468 1471
51. Krupp LB, Soefer MH, Pollina DA, et al. Fatigue measures for clinical trials in multiple sclerosis. Neurology 1998;50:A126.
52. L.B. Krupp, P.K. Coyle, and C. Doscher Fatigue therapy in multiple sclerosis: results of a double blind, randomized, parallel trial of amantadine, pemoline, and placebo Neurology 45 1995 1956 1961
53. K.W. Rammohan, J.H. Rosenberg, and D.J. Lynn Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two-centre phase 2 study J Neurol Neurosurg Psychiatry 72 2 2002 179 183
54. G.L. Sheean, N.M. Murray, and J.C. Rothwell An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis Brain 121 Pt 5 1998 967 975
55. J.E. Schwartz, L. Jandorf, and L.B. Krupp The measurement of fatigue: a new scale J Psychosom Res 37 7 1993 753 762
56. J.D. Fisk, P.G. Ritvo, and L. Ross Measuring the functional impact of fatigue: initial validation of the fatigue impact scale Clin Infect Dis 18 Suppl 1 1994 S79 S83
57. S.R. Schwid, M. Covington, and B.M. Segal Fatigue in multiple sclerosis: current understanding and future directions J Rehabil Res Dev 39 2 2002 211 224
58. P.M. Meek, L.M. Nail, and A. Barsevik Psychometric testing of fatigue instruments for use with cancer patients Nurs Res 49 2000 181 190
59. G. Sutherland, and M.B. Anderson Exercise and multiple sclerosis: physiological, psychological, and quality of life stress Journal of Sports Medicine & Physical Fitness 41 2002 421 432
60. S. Mostert, and J. Kesselring Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis Mult Scler 8 2 2002 161 168
61. J.H. Petajan, E. Gappmaier, and A.T. White Impact of aerobic training on fitness and quality of life in multiple sclerosis Ann Neurol 39 4 1996 432 441
62. R.P. Di Fabio, J. Soderberg, and T. Choi Extended outpatient rehabilitation: it's influence on symptom frequency, fatigue and functional status for persons with progressive multiple sclerosis Arch Phys Med Rehabil 79 1998 141 146
63. L.B. Krupp Fatigue in multiple sclerosis: a guide to diagnosis and management 2004 Demos Medical Publishing, Inc. New York
64. T.C. Guthrie, and D.A. Nelson Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential J Neurol Sci 129 1 1995 1 8
65. G. Flesner, and C. Lindencrona The cooling-suit: case studies of its influence on fatigue among eight individuals with multiple sclerosis [abstract] J Adv Nurs 37 6 2002 541 550
66. E.A. Beenakker, T.I. Oparina, and A. Hartgring Cooling garment treatment in MS: clinical improvement and decrease in leukocyte NO production Neurology 57 5 2001 892 894
67. A.T. White, T.E. Wilson, and S.L. Davis Effect of precooling on physical performance in multiple sclerosis Mult Scler 6 3 2000 176 180
68. D.A. Woods Aquatic exercise programs for patients with multiple sclerosis Clin Kinesiol 46 3 1992 14 20
69. C. Peterson Exercise in 94°F water for a patient with multiple sclerosis Phys Ther 81 4 2001 1049 1058
70. V. Mathiowetz, K.M. Matuska, and M.E. Murphy Efficacy of an energy conservation course for persons with multiple sclerosis Arch Phys Med Rehabil 82 4 2001 449 456
71. S.M. Vanage, K.K. Gilbertson, and V. Mathiowetz Effects of an energy conservation course on fatigue impact for persons with progressive multiple sclerosis Am J Occup Ther 57 3 2003 315 323
72. Schapiro RT for the Working Group for Pharmacologic Therapy in Multiple Sclerosis-Related Fatigue MS-related fatigue: toward a consensus for pharmacologic therapy Int J MS Care 4 Suppl 2002 1 16
73. Symmetrel (Amantadine) package insert 2000 Endo Pharmaceuticals Chadds Ford (PA)
74. Canadian MS Research Group A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis Can J Neural Sci 14 1987 273 278
75. J.S. Lin, Y. Hou, and M. Jouvet Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat Proc Natl Acad Sci USA 93 1996 14128 14133
76. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group Neurology 54 5 2000 1166 1175
77. I. Arnulf, P. Homeyer, and L. Garma Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients Respiration (Herrlisheim) 64 2 1997 159 161
78. J.W. Cochran Effect of modafinil on fatigue associated with neurological illnesses J Chronic Fatigue Syndr 8 2001 65 70
79. U.A. Zifko, M. Rupp, and S. Schwarz Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study J Neurol 249 8 2002 983 987
80. Cylert (pemoline) package insert 2004 Abbott Laboratories Chicago
81. J.D. Duffy, and J. Campbell Bupropion for the treatment of fatigue associated with multiple sclerosis Psychosomatics 35 2 1994 170 171
82. D.C. Mohr, S.L. Hart, and A. Goldberg Effects of treatment for depression on fatigue in multiple sclerosis Psychosom Med 65 4 2003 542 547
83. C.H. Polman, F.W. Bertelsmann, and R. de Waal 4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis Arch Neurol 51 1994 1136 1139
84. C.H. Polman, F.W. Bertelsmann, and A.C. Van Loenen 4-Aminopyridine in the treatment of patients with multiple sclerosis. Long term efficacy and safety Arch Neurol 51 1994 292 296
85. G. Gillson, T.L. Tichard, and R.B. Smith A double blind pilot study of the effect of Prokarin on fatigue in multiple sclerosis [abstract] Mult Scler 8 1 2002 30 35